Prostate Cancer: Shortened radiation therapy for high-risk patients confirmed safe
A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase III clinical trial is the first to confirm the safety and efficacy of a moderately shortened course of radiation exclusively for patients with high-risk disease. Findings from the Prostate Cancer Study […]
Prostate Cancer: Shortened radiation therapy for high-risk patients confirmed safe Read More »
